|
Re: Apabetalone for non diabetics or normal cholesterol?
|
4
|
Resverlogix Corp.
|
Dec 10, 2019 10:33AM
|
|
Re: How is Zenith affected by the RVX top line miss
|
4
|
Zenith Epigenetics
|
Sep 30, 2019 07:15PM
|
|
Re: New insights from this study -- Questions for scientists.
|
4
|
Resverlogix Corp.
|
Jun 10, 2022 07:19AM
|
|
Re: For sake of argument lets say ..
|
4
|
Zenith Epigenetics
|
Jun 01, 2022 06:58AM
|
|
Re: Clinicaltrials.gov
|
4
|
Zenith Epigenetics
|
May 13, 2018 03:15PM
|
|
Re: Review of ZCC history
|
4
|
Zenith Epigenetics
|
Aug 29, 2023 09:50AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
4
|
Zenith Epigenetics
|
Jan 30, 2019 07:36AM
|
|
Re: Thoughts on ZCC
|
4
|
Zenith Epigenetics
|
Sep 05, 2021 09:42AM
|
|
Re: Additional Exempt Distribution- 2023-03-31
|
4
|
Zenith Epigenetics
|
Apr 16, 2023 07:45PM
|
|
Re: The latest numbers for Alberta.
|
4
|
Resverlogix Corp.
|
Sep 17, 2021 11:26AM
|
|
Re: While we wait…
|
4
|
Resverlogix Corp.
|
Jun 14, 2024 11:26AM
|
|
Re: What credibility?
|
4
|
Resverlogix Corp.
|
Aug 27, 2017 02:24PM
|
|
Pfizer seems like a good fit for a BP deal
|
4
|
Zenith Epigenetics
|
Jan 08, 2024 06:30PM
|
|
Re: 2 year extension
|
4
|
Resverlogix Corp.
|
May 14, 2024 02:26PM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
4
|
Zenith Epigenetics
|
Oct 08, 2024 03:53PM
|
|
Re: OTC Trading questions
|
4
|
Zenith Epigenetics
|
Mar 02, 2022 10:20AM
|
|
Re: Review of ZCC history
|
4
|
Zenith Epigenetics
|
Aug 29, 2023 11:40AM
|
|
Re: What's the deal?
|
4
|
Resverlogix Corp.
|
Nov 30, 2020 01:57PM
|
|
Re: proxy vote
|
4
|
Resverlogix Corp.
|
Sep 28, 2019 03:47PM
|
|
Re: Zenith AGM Dec 15
|
4
|
Zenith Epigenetics
|
Oct 16, 2016 04:22PM
|
